MedTrace Logo

Effect of 50 and 100 IU Doses of Botox A Toxin Injection in BPH Patients.

NCT02524236 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-02-20

No results posted yet for this study

Summary

The primary objective of this study is to compare the efficacy and safety of a single injection of 50 U and 100 U doses of BoNT-A for the treatment of BPH-associated LUTS.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

DRUG

Botox injection in the prostate

transrectal access of prostatic injection

Sponsors & Collaborators

  • Beni-Suef University

    lead OTHER

Principal Investigators

  • Ahmed M Abdelbary, md · Beni-Suef University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
50 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02524236 on ClinicalTrials.gov